Showing results (61-70 of 160) with videos related to
Sort By:
Pageof 16
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 25, 2020
Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in FranceSalah Ghabri, Aymeric Binard, Yves-Marie Pers, et al.Pharmacoeconomics|July 27, 2002
Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in SwedenFrances B Garfield, Denis Getsios, J Jaime Caro, et al.Pharmacoeconomics|July 1, 2005
Costs and medical care consequences associated with the diagnosis of peripheral arterial diseaseKristen Migliaccio-Walle, J Jaime Caro, Khajak J Ishak, et al.Molecular and Cellular Biology|March 2, 2006
Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alphaXianguo Kong, Zhao Lin, Dongming Liang, et al.Current Medical Research and Opinion|February 24, 2009
Cost-benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in CanadaH Baris Deniz, Alexandra Ward, J Jaime Caro, et al.The Spine Journal : Official Journal of the North American Spine Society|September 15, 2009
Can cost utility evaluations inform decision making about interventions for low back pain?Simon Dagenais, Darren M Roffey, Eugene K Wai, et al.Cerebrovascular Diseases (Basel, Switzerland)|August 30, 2008
The prognostic value of the modified Rankin Scale score for long-term survival after first-ever stroke. Results from the Athens Stroke RegistryKrista F Huybrechts, J Jaime Caro, James J Xenakis, et al.The Journal of Biological Chemistry|April 4, 2007
Constitutive/hypoxic degradation of HIF-alpha proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the proteinXianguo Kong, Beatriz Alvarez-Castelao, Zhao Lin, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 13, 2008
Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in ItalyHuseyin Baris Deniz, J Jaime Caro, Alexandra Ward, et al.BMC Geriatrics|December 17, 2003
Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysisJaime Caro, Denis Getsios, Kristen Migliaccio-Walle, et al.Pageof 16